Company Filing History:
5 out of 1,210 
1 out of 1,386 
Years Active: 2019-2024
Title: David Barbie: Innovator in Cancer Research
Introduction
David Barbie is a prominent inventor based in Andover, MA (US), known for his significant contributions to cancer research. He holds a total of 5 patents that focus on innovative methods for evaluating tumor cells and identifying biomarkers for cancer immunotherapy. His work has the potential to greatly impact the field of oncology.
Latest Patents
One of David Barbie's latest patents is titled "Methods for evaluating tumor cell spheroids using 3D microfluidic cell culture device." This patent describes methods for evaluating tumor cell spheroids in a three-dimensional microfluidic device by determining changes in the relative levels of live cells and dead cells in aliquots cultured under different conditions. Additionally, it outlines methods for allowing ex vivo recapitulation of the tumor microenvironment, which can help predict the in vivo effectiveness of test compounds in treating tumor tissue. Another significant patent is "STING levels as a biomarker for cancer immunotherapy." This patent provides insights into Stimulator of Interferon Genes (STING) and Stimulated 3 Prime Antisense Retroviral Coding Sequences (SPARCS) genes as biomarkers for determining effective therapies for treating cancer. It also includes methods for treating cancer using these biomarkers.
Career Highlights
David Barbie has worked with esteemed organizations such as Dana-Farber Cancer Institute Inc. and Brigham and Women's Hospital, Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field of cancer research.
Collaborations
Some of his notable coworkers include Amir Aref and Russell W. Jenkins. Their collaborative efforts have contributed to advancing research in cancer therapies and diagnostics.
Conclusion
David Barbie's innovative work in cancer research, particularly through his patents, showcases his commitment to improving treatment options for patients. His contributions are paving the way for future advancements in the field of oncology.